| Precision Therapeutics is a CLIA-certified clinical laboratory |
Bladder Cancer
Bladder cancer forms in the tissues of the bladder. Most bladder cancers are transitional cell carcinomas. Other bladder cancer types include squamous cell carcinomas and adenocarcinomas. The cells that form these cancers develop in the inner lining of the bladder, resulting in chronic irritation and inflammation. These cancerous cells can also grow throughout the urinary tract. When diagnosed with bladder cancer, the entire urinary tract needs to be examined for tumors.
Bladder Cancer Treatment Options
Bladder cancer treatment options are determined by the type and stage of bladder cancer and include surgery, radiation therapy and chemotherapy. Chemotherapy is a common treatment for bladder cancer. It is sometimes given before surgery (neoadjuvant chemotherapy) to shrink the tumor for easier removal. Chemotherapy can also be given after surgery (adjuvant chemotherapy) to kill any remaining cancer cells. This can lower a patient’s risk of recurrence.
Bladder Cancer and ChemoFx®
For bladder cancer patients receiving chemotherapy, whether as neoadjuvant chemotherapy, adjuvant chemotherapy, primary chemotherapy or combination chemotherapy, ChemoFx® can assist physicians in selecting personalized cancer treatment plans. Physicians can use ChemoFx® as a guide by testing multiple chemotherapy drugs on a patient's cancer cells before choosing one for their patient, giving patients a powerful advantage in their fight against cancer. For more information on ChemoFx® , visit http://www.chemofx.com.
Information for this webpage was gathered from the following websites:
www.cancer.gov
www.cancer.org
www.chemofx.com